BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang ZM, Guo JX, Zhang ZC, Jiang N, Zhang ZY, Pan LJ. Therapeutic options for intermediate-advanced hepatocellular carcinoma. World J Gastroenterol 2011; 17(13): 1685-1689 [PMID: 21483627 DOI: 10.3748/wjg.v17.i13.1685]
URL: https://www.wjgnet.com/1948-5182/full/v17/i13/1685.htm
Number Citing Articles
1
Muhammad Tarek Abdel Ghafar, Morad Ahmed Morad, Enas A. El-Zamarany, Dina Ziada, Hanan Soliman, Sherief Abd-Elsalam, Marwa Salama. Autologous dendritic cells pulsed with lysate from an allogeneic hepatic cancer cell line as a treatment for patients with advanced hepatocellular carcinoma: A pilot studyInternational Immunopharmacology 2020; 82: 106375 doi: 10.1016/j.intimp.2020.106375
2
Mattia Garancini, Enrico Pinotti, Stefano Nespoli, Fabrizio Romano, Luca Gianotti, Vittorio Giardini. Hepatic resection beyond barcelona clinic liver cancer indication: When and howWorld Journal of Hepatology 2016; 8(11): 513-519 doi: 10.4254/wjh.v8.i11.513
3
Peng-Sheng Yi, Ming Zhang, Ji-Tong Zhao, Ming-Qing Xu. Liver resection for intermediate hepatocellular carcinomaWorld Journal of Hepatology 2016; 8(14): 607-615 doi: 10.4254/wjh.v8.i14.607
4
Eric Stokes, Tian Shuang, Yanjie Zhang, Yanxi Pei, Ming Fu, Baoqing Guo, Amadeo Parissenti, Lingyun Wu, Rui Wang, Guangdong Yang. Efflux inhibition by H2S confers sensitivity to doxorubicin-induced cell death in liver cancer cellsLife Sciences 2018; 213: 116 doi: 10.1016/j.lfs.2018.10.031
5
T.J. Vogl, B. Panahi, S. Fischer, N. Naguib, N.-E.A. Nour-Eldin, T. Gruber, J. Trojan, W. Bechstein, S. Zangos, K. Eichler. Interventionelle Therapie von Lungen- und LebermetastasenDer Onkologe 2014; 20(8): 746 doi: 10.1007/s00761-014-2669-3
6
Felipe Nasser, Rafael N. Cavalcante, Francisco L. Galastri, Marcelo B. de Rezende, Guilherme G. Felga, Fabiellen B. Travassos, Bruna De Fina, Breno B. Affonso. Safety and Feasibility of Same-Day Discharge of Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization with Drug-Eluting Beads in a Liver Transplantation ProgramJournal of Vascular and Interventional Radiology 2014; 25(7): 1012 doi: 10.1016/j.jvir.2014.02.025
7
Yuxin Zhou, Na Lu, Haiwei Zhang, Libin Wei, Lei Tao, Qinsheng Dai, Li Zhao, Biqi Lin, Qilong Ding, Qinglong Guo. HQS-3, a newly synthesized flavonoid, possesses potent anti-tumor effect in vivo and in vitroEuropean Journal of Pharmaceutical Sciences 2013; 49(4): 649 doi: 10.1016/j.ejps.2013.04.016
8
Gang Dong, Xia‑Hui Lin, Hua‑Hua Liu, Dong‑Mei Gao, Jie‑Feng Cui, Zheng‑Gang Ren, Rong‑Xin Chen. Intermittent hypoxia alleviates increased VEGF and pro‑angiogenic potential in liver cancer cellsOncology Letters 2019;  doi: 10.3892/ol.2019.10486
9
Y.-G. Wang, L. Li, C.-H. Liu, S. Hong, M.-J. Zhang. Peroxiredoxin 3 is resistant to oxidation-induced apoptosis of Hep-3b cellsClinical and Translational Oncology 2014; 16(6): 561 doi: 10.1007/s12094-013-1117-y
10
Philippe Kolly, Helen Reeves, Bruno Sangro, Marina Knöpfli, Daniel Candinas, Jean-François Dufour. Assessment of the Hong Kong Liver Cancer Staging System in EuropeLiver International 2016; 36(6): 911 doi: 10.1111/liv.13045
11
Koichiro Yamakado, Shozo Hirota. Sub-classification of intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinomasWorld Journal of Gastroenterology 2015; 21(37): 10604-10608 doi: 10.3748/wjg.v21.i37.10604
12
Fan Cheung, Xuanbin Wang, Ning Wang, Man-Fung Yuen, Tat-chi Ziea, Yao Tong, Vivian Taam Wong, Yibin Feng. Chinese Medicines as an Adjuvant Therapy for Unresectable Hepatocellular Carcinoma during Transarterial Chemoembolization: A Meta-Analysis of Randomized Controlled TrialsEvidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/487919
13
Jian-Hong Zhong, A. Chapin Rodríguez, Yang Ke, Yan-Yan Wang, Lin Wang, Le-Qun Li. Hepatic Resection as a Safe and Effective Treatment for Hepatocellular Carcinoma Involving a Single Large Tumor, Multiple Tumors, or Macrovascular InvasionMedicine 2015; 94(3): e396 doi: 10.1097/MD.0000000000000396
14
Giovan Giuseppe Di Costanzo, Raffaella Tortora. Intermediate hepatocellular carcinoma: How to choose the best treatment modality?World Journal of Hepatology 2015; 7(9): 1184-1191 doi: 10.4254/wjh.v7.i9.1184
15
Asmaa I Gomaa, Imam Waked. Recent advances in multidisciplinary management of hepatocellular carcinomaWorld Journal of Hepatology 2015; 7(4): 673-687 doi: 10.4254/wjh.v7.i4.673
16
Duraikannu Arul, Perumal Subramanian. Naringenin (Citrus Flavonone) Induces Growth Inhibition, Cell Cycle Arrest and Apoptosis in Human Hepatocellular Carcinoma CellsPathology & Oncology Research 2013; 19(4): 763 doi: 10.1007/s12253-013-9641-1
17
Wei Liu, Jian-Guo Zhou, Yi Sun, Lei Zhang, Bao-Cai Xing. Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma in Asia: a Systematic Review and Meta-AnalysisJournal of Gastrointestinal Surgery 2015; 19(7): 1271 doi: 10.1007/s11605-015-2811-6
18
Hyunsoo Kim, Su Jong Yu, Injun Yeo, Young Youn Cho, Dong Hyeon Lee, Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Sungyoung Lee, Jongsoo Jun, Taesung Park, Jung-Hwan Yoon, Youngsoo Kim. Prediction of Response to Sorafenib in Hepatocellular Carcinoma: A Putative Marker Panel by Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS)Molecular & Cellular Proteomics 2017; 16(7): 1312 doi: 10.1074/mcp.M116.066704
19
Zhi-Bo Xie, Liang Ma, Xiao-Bo Wang, Tao Bai, Jia-Zhou Ye, Jian-Hong Zhong, Le-Qun Li. Transarterial embolization with or without chemotherapy for advanced hepatocellular carcinoma: a systematic reviewTumor Biology 2014; 35(9): 8451 doi: 10.1007/s13277-014-2340-z
20
Maria Tampaki, Polyxeni P Doumba, Melanie Deutsch, John Koskinas. Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insightsWorld Journal of Hepatology 2015; 7(14): 1834-1842 doi: 10.4254/wjh.v7.i14.1834
21
T.J. Vogl, F. Marquardt, W. Bechstein, J. Trojan, N.N.N. Naguib, T. Gruber-Rouh, M. Beeres, C. Lee. Interventionelle Therapie primärer LebertumorenDer Onkologe 2012; 18(7): 593 doi: 10.1007/s00761-012-2237-7
22
Samar S. Azab, Mohamed Abdel-Daim, Omayma A. Eldahshan. Phytochemical, cytotoxic, hepatoprotective and antioxidant properties of Delonix regia leaves extractMedicinal Chemistry Research 2013; 22(9): 4269 doi: 10.1007/s00044-012-0420-4
23
Yuichi Sugino, Koichiro Yamakado, Takashi Yamanaka, Masashi Fujimori, Atsuhiro Nakatsuka, Haruyuki Takaki, Yoshiyuki Takei, Hajime Sakuma, Shuji Isaji. Role of curative treatment in patients with intermediate-stage hepatocellular carcinomaJapanese Journal of Radiology 2017; 35(5): 254 doi: 10.1007/s11604-017-0628-9
24
J.-F. Dufour, I. Bargellini, N. De Maria, P. De Simone, I. Goulis, R.T. Marinho. Intermediate hepatocellular carcinoma: current treatments and future perspectivesAnnals of Oncology 2013; 24: 24 doi: 10.1093/annonc/mdt054
25
LILI ZHANG, SU YU, ZHIJUN DUAN, QIUMING WANG, GE TIAN, YAN TIAN, WEI ZHAO, HUI WANG, CUILING ZHANG, SHIBIN GUO, QIGUI LIU, GAOHONG HE, TENGFEI BIAN, JIUYANG CHANG, XUE JIN, DONGSHENG CUI. Treatment of liver cancer in mice by the intratumoral injection of an octreotide-based temperature-sensitive gelInternational Journal of Molecular Medicine 2014; 33(1): 117 doi: 10.3892/ijmm.2013.1542